arrow
V

Vahan Képénékian

hopital lyon sud
H指数:31
被引数:3,964

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prophylactic ureteral stenting during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Impact on symptomatic ureteral events requiring renal drainage

在细胞减灭术和温热腹腔化疗期间进行预防性输尿管支架置入:对需要肾脏引流的有症状输尿管事件的影响

EJSO
IF2.9
2026-10-120
OA
Molecular profiling and personalized medicine within EURACAN in the SPECTA Arcagen study in comparison to the France Genomic Medicine 2025 Plan in the AURAGEN platform in peritoneal mesotheliomas

EURACAN框架下SPECTA Arcagen研究中的分子谱分析与个性化医学,与法国基因组医学2025计划中AURAGEN平台在腹膜间皮瘤中的比较

2026-05-180
OAAI
Neoadjuvant chemotherapy for obstructive colon cancer derived by a stoma: Study protocol of the FRENCH-01 randomized phase III trial (COnCERTO Trial)

由造口术衍生的梗阻性结肠癌的新辅助化疗:FRENCH-01随机III期试验(COnCERTO试验)研究方案

2026-04-060
OAAI
Feasibility and safety profile of high-dose oxaliplatin-based PIPAC (120mg/m2) in the treatment of advanced peritoneal metastatic disease: MINOS real-life multicenter study

高剂量奥沙利铂为基础的PIPAC(120mg/m²)治疗晚期腹膜转移性疾病的可行性与安全性特征:MINOS真实世界多中心研究

2026-03-040
OAAI
Feasibility of ERAS guidelines for cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (CRS-HIPEC): An international multicenter study

ERAS指南在细胞减灭术联合或未联合温热腹腔灌注化疗(CRS-HIPEC)中的可行性:一项国际多中心研究

2026-01-310
OAAI
ASO Visual Abstract: Appendiceal Adenocarcinoma Discovered during Acute Perforated Appendicitis: A Potential Contribution of Prophylactic CRS and HIPEC, a French BIGRENAPE Group Study

ASO视觉摘要:急性穿孔性阑尾炎期间发现的阑尾腺癌:预防性CRS和HIPEC的潜在贡献,法国BIGRENAPE研究小组研究

2026-01-070
PRE
Correction: Appendiceal Adenocarcinoma Discovered During Acute Perforated Appendicitis: A Potential Contribution of Prophylactic CRS and HIPEC—A French BIGRENAPE Group Study

更正:急性穿孔性阑尾炎期间发现的阑尾腺癌:预防性CRS和HIPEC的潜在贡献——法国BIGRENAPE小组研究

2025-12-140
OAAI
Appendiceal Adenocarcinoma Discovered During Acute Perforated Appendicitis: A Potential Contribution of Prophylactic CRS and HIPEC—A French BIGRENAPE Group Study

阑尾腺癌在急性穿孔性阑尾炎中发现:预防性CRS和HIPEC的潜在贡献——法国BIGRENAPE研究组研究

2025-11-250
PRE
Multiparametric assessment of tumor pathological regression grade of peritoneal metastases from non-mucinous colorectal cancer during neoadjuvant chemotherapy using dual-energy CT

使用双能量CT对非黏液性结直肠癌腹膜转移灶在化疗新辅助治疗期间进行多参数评估肿瘤病理退缩分级

2025-10-310
PRE
ASO Author Reflections: Preoperative Peritoneal MRI Used as the Peritoneal Surgeon’s Headlamp Helping to Achieve a Complete Cytoreductive Surgery in Patients with Abdominal Surgical History

ASO作者反思:作为腹腔外科医生“探照灯”的术前腹膜MRI,有助于在具有腹部手术史的患者中实现完全细胞减灭术。

2025-10-060
PRE
Assessing the Annual Risk of Recurrence Following Complete Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Diffuse Malignant Peritoneal Mesothelioma Patients

评估弥漫性恶性腹膜间皮瘤患者行完全细胞减灭术联合温热腹腔化疗(HIPEC)后的年度复发风险

2025-09-260
PRE
ASO Visual Abstract: Preoperative Peritoneal MRI: Usefulness to Highlight Potential Hidden Lesions for Complete Cytoreductive Surgery in Colorectal Cancer Patients with Surgical History

ASO视觉摘要:术前腹膜MRI:在具有手术史的大肠癌患者中,完全细胞减灭术用于突出潜在隐匿病灶的实用性

2025-09-090
PRE
Preoperative Peritoneal MRI: Usefulness to Highlight Potential Hidden Lesions for Complete Cytoreductive Surgery in Patients with Colorectal Cancer with Surgical History

术前腹膜MRI:用于结直肠癌有手术史患者的完全细胞减灭术,以突出潜在隐匿病灶的实用性

2025-08-060
OAAI